PRTN3 and rheumatoid arthritis: For the future, assays containing a mixture of citrullinated, carbamylated and acetylated peptides might indeed reduce the serological gap (29) and further increase specificity of ACPA testing because the presence of multiple reactivities has been reported to be highly specific for RA (10, 30).